文献速递血脂与心血管预防

调脂药物用于COVID-19预防或治疗的研究综述

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

本文综述调脂药物在COVID-19中的潜在作用机制及正在进行的随机对照试验。通过系统检索共识别40项RCT,包括他汀17项、ω-3脂肪酸14项、贝特类3项、烟酸5项、dalcetrapib 1项,仅2项报告初步结果,多数仍在进行中。

要点

  • 调脂药物可能通过破坏脂筏抑制病毒进入或改善炎症和内皮活化。
  • 低HDL-C和高甘油三酯与COVID-19更差结局相关。
  • 已识别40项RCT,仅2项有初步结果,多数正在进行。

核心结论

  • 调脂药物在COVID-19中可能具有治疗潜力,但已识别的40项RCT中仅2项报告初步结果,多数仍在进行中。

研究设计与样本

  • 系统检索识别40项调脂药物用于COVID-19管理或预防的RCT,含他汀17项、ω-3脂肪酸14项、贝特类3项、烟酸5项、dalcetrapib 1项。

主要发现

  • 已识别的40项RCT中仅2项报告初步结果,其余多数正在进行。
  • COVID-19与系统性炎症、内皮活化及多器官表现相关。
  • 低HDL-C和高甘油三酯水平预示COVID-19患者结局更差。

临床怎么用

  • 本文总结正在或已完成调脂药物RCT及其对患者管理的意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be useful in treating patients with COVID-19. These agents may inhibit viral entry by lipid raft disruption or ameliorate the inflammatory response and endothelial activation. In addition, dyslipidemia with lower high-density lipoprotein cholesterol and higher triglyceride levels portend worse outcomes in patients with COVID-19. Upon a systematic search, 40 randomized controlled trials (RCTs) with lipid-modulating agents were identified, including 17 statin trials, 14 omega-3 fatty acids RCTs, 3 fibrate RCTs, 5 niacin RCTs, and 1 dalcetrapib RCT for the management or prevention of COVID-19. From these 40 RCTs, only 2 have reported preliminary results, and most others are ongoing. This paper summarizes the ongoing or completed RCTs of lipid-modulating agents in COVID-19 and the implications of these trials for patient management.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, et al. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 34649702. doi:10.1016/j.jacc.2021.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。